Dube Michael P
Reporting owner on Forms 3, 4 and 5, CIK 2019493.
Dube Michael P reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NTLA · Intellia Therapeutics, Inc.CIK 1652130 | officer (VP, Chief Accounting Officer) | 1 | 2026-10-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NTLA · Intellia Therapeutics, Inc.Common Stock | 2026-10-02 | S sold | -1,864 | $12.43 | 65,022 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-415541 | Intellia Therapeutics, Inc. | 2026-10-06 |